Cleveland, OH — If you’re like us, the bottom of your inbox is usually cluttered with emails you really mean to get back to, including lots of newsletters and alerts full of great research and insight. With more emails arriving every moment, it’s hard to ever catch up. So, as part of our new year’s resolutions, we read them all and found three you will not want to miss:
- PwC conducted new research into what patients want today
- CMI/Compas got doctors’ reactions to The Sunshine Act
- Rock Health showed us where the digital health investment is
Here are the highlights (and, don’t save this for later!)
Ok, the big one first:
#1 PwC: Customer Experience In the Pharmaceutical Sector
More than 700 U.S. consumers and several leaders at retail and pharma brands contributed to this report about starting and sticking with medication. The landscape has really changed. Of course, there are still many consumers who have limited veto power over the type and price of medication they take, but there’s also a growing segment who have high-deductible insurance plans and are much less passive consumers of pharmaceuticals.
On both sides of the market, consumers have strong views on the pharma industry and big expectations for it should evolve to deliver experiences more like the ones they have with brands in other categories.
In other words, today’s patient is moving from a passive recipient of healthcare to an independent decision maker. That’s creating a lot of interesting new behaviors – and, some very familiar old ones.
Oh, and one other thing: Here’s a new dictionary of all the industry slang around how people really (don’t) use as directed:
#2 CMI/Compas: The Sunshine Act
You’ve probably already heard a lot of talk about The Physician Payment Sunshine Act. It creates new reporting rules for exchanges of value between pharma and physicians.
Want more on the Act? Here’s a great summary.
To understand more about how the law will change the industry, CMI/Compas interviewed both primary care physicians and pharma industry experts to understand their perspectives. They identified gaps in both understanding and expectation.
Even when the rules were explained, physicians didn’t expect to radically change their behavior. There’s a lot they value and still need from pharma, but participation with some offerings will decrease.
#3 Rock Health: 2013 Digital Health Funding Report
Rock Health is one of the biggest names in venture capital for digital health. And, they’re a go-to source for knowing where investors are placing their bets. Since their first report in 2011, digital health funding has more than doubled — exceeding $1.9B with 195 venture deals ($2M+) in 2013. In 2014, the digital health industry is set to surpass total medical device venture funding. Pretty cool, right?
186 digital health companies each raise $2 million in 2013, but these deals were the biggest of the big:
Posted by: Leigh Householder